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ABSTRACT  
The present investigation is concerned with formulation and evaluation of Transdermal gels of Tacrolimus, anti-psoriasis drug, to circumvent 
the first pass effect and to improve its bioavailability with reduction in dosing frequency and dose related side effects. Twelve formulations 
were developed with varying concentrations of polymers like Carbopol 934P, HPMCK4M and Sodium CMC. The gels were tested for c larity, 
Homogeneity, Spreadability, Extrudability, Viscosity, surface pH, drug Content uniformity, in-vitro drug diffusion study and ex-vivo permeation 
study using rat abdominal skin. FTIR studies showed no evidence on interactions between drug, polymers and excipients.  The best in-vitro drug 
release profile was achieved with the formulation F4 containing 0.5 mg of exhibited 6 hr drug release i.e. 98.68 % with desired therapeutic 
concentration which contains the drug and Carbopol 934p in the ratio of 1:2. The surface pH, drug content and viscosity of the formulation F4 
was found to be 6.27, 101.3% and 3, 10,000cps respectively. The drug permeation from formulation F4 was slow and steady and 0.89gm of 
tacrolimus could permeate through the rat abdominal skin membrane with a flux of 0.071 gm hr-1 cm-2. The in-vitro release kinetics studies 
reveal that all formulations fit well with zero order kinetics followed by non-Fickian diffusion mechanism.  
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INTRODUCTION 
The Trans dermal drug delivery systems are self-contained, 
discrete dosage forms which when applied to intact skin 
deliver the drug through the skin at a controlled rate to the 
systemic circulation. At Present, the most common form of 
delivery of drugs is the oral route. While this has the notable 
advantages of easy administration, it also has significant 
drawbacks namely poor bioavailability due to hepatic 
metabolism (first pass) and the tendency to produce rapid 
blood level spikes leading to a need for high and/or frequent 
dosing, which can be both cost prohibitive and involvement. 
To overcome these difficulties there is a need for the 
development of new drug delivery system; which will 
improve the therapeutic efficacy and safety of drugs by more 
precise (i.e. site specific), spatial and temporal.1-3 
Placement with in the body thereby reducing both size and 
number of doses. One of the methods most often utilized has 
been Transdermal delivery. This delivery transport 
therapeutic substance through The skin for systemic effect. 
The success of Tran’s dermal delivery depends on the ability 
of the drug to permeate the skin in sufficient quantities to 
achieve its desired therapeutic effects. The skin is very 
effective as a selective penetration barrier. Percutaneous 
absorption involves the passage of the drug molecule from 
the skin surface into the stratum corneum under the 
influence of a concentration gradient and its subsequent 
diffusion through the stratum corneum and underlying 
epidermis through the dermis and into the blood circulation. 
The skin behaves as a passive barrier to the penetrating 
molecule. The stratum corneum provides the greatest 
resistance to penetration and it is the rate-limiting step in 
percutaneous absorption. Gels are transparent to opaque 
semisolids containing high ratio of solvent to gelling agent 
merge or entangle to form a three-dimensional colloidal 
network structure. This network limits fluid flow by 
entrapment and immobilization of the solvent molecules. 
The network structure is also responsible for a gel resistance 
to deformation and therefore, its visco-elastic properties. 
Gels tend to be smooth, elegant, non-greasy and produce 
cooling effect and utilize better drug release as compared to 
other semisolid formulation. Gels have better potential as a 
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vehicle to administered drug topically in comparison to 
ointment, because they are non-sticky requires low energy 
during the formulation are stable and have aesthetic value 4-
6. 
Tacrolimus (FK 506) is an effective and well-tolerated 
primary immunosuppressant drug used in solid organ 
transplantation. Although its mode of action is similar to that 
of cyclosporine, its molecular weight is lower and its potency 
in inhibiting T-cell activation is 10 to 100 times greater. 
Moreover, topically applied tacrolimus appears to penetrate 
the skin sufficiently to affect local immunosuppressant. 
Molecular Weight is 296.149; Protein binding More than 
99%, Metabolism by Hepatic Excretion of the unchanged 
drug in urine and faeces is negligible. 
Generally the formulations of Tacrolimus commercially 
available are in oral and ointment form. More recently, a 
topical gel formulation will be introduced specifically for the 
treatment of localized painful and inflammatory condition, 
such as soft tissue musculoskeletal disorders and 
osteoarthritis. So the present study, formulation and 
evaluation of Tacrolimus transdermal gel will attempt to 
increase the efficacy of the drug at the site of action. 
MATERIALS AND METHODS 
Materials:  
Tacrolimus was a gift sample from Yacht Parma, Hyderabad. 
Carbopol 934P and Sodium CMC were purchased from S.D. 
Fine chem. Ltd, Mumbai. HPMCK4M was purchased from 
Yarrow chemicals ltd, Mumbai. All other reagents used were 
of analytical grade. 
Preformulation studies: 7-9 
Characterization of Tacrolimus:  
Description 
The sample of tacrolimus was analyzed for its nature, colour 
and taste. 
Melting Point 
The melting point was determined by using these are tube 
apparatus method. 
Drug Excipientcompatibility studies: 
The drug polymer and polymer-polymer interaction was 
studied by the FTIR spectrometer using Shimadzu 8400-S, 
Japan. Two percent (w/w) of the sample with respect to a 
potassium bromide disc was mixed with dry KBr. The 
mixture was grind into a fine powder using an agate mortar 
and then compressed into a KBr disc in a hydraulic press at a 
pressure of 1000psi. Each KBr disc was scanned 16times at 2 
mm/sec at a resolution of 4 cm-1 using cosine apodization. 
The characteristic peaks we rerecorded. 
Preparation of Transdermal Gels 
1% w/w Tacrolimus Transdermal gels were prepared by 
using different Concentrations of polymers such as Carbopol 
934P, HPMCK4M and Sodium CMC. The formulation data for 
the preparation of Diclofenac sodium Transdermal gels 
using Carbopol 934P, HPMCK4M and Sodium CMC in 
different ratio’s is shown in [Tables 01] 
Procedure: 
Accurately weighed amount of Polymers (Carbopol 934P, 
HPMC K4M and Sodium CMC) in four different ratios was 
placed in known amount of distilled water (Twelve different 
formulations were prepared using varying concentrations of 
Carbopol 934P, HPMC K4M and Sodium CMC). After 
complete dispersion, the polymer solution was kept in dark 
for 24 hours for complete swelling. Accurately weighed 
amount of Tacrolimus was dissolved in a specified quantity 
of suitable solvent. The drug solution was added slowly to 
the aqueous dispersion of polymer with the help of high 
speed stirrer (500 rpm) taking precaution that air did not 
entrap. Finally, the remaining ingredients were added to 
obtain a homogeneous dispersion of gel. 
Evaluation of Gels 
About twelve formulations i.e. F1 to F12 were conducted. 
Gels were evaluated for their clarity, pH, viscosity, 
Spreadability, Extrudability, skin irritation test, percentage 
drug content, in-vitro diffusion studies, in-vitro drug release 
kinetic study, ex-vivo permeation studies using rat 
abdominal skin and stability studies by using standard 
procedure. All studies were carried out in triplicate and 
average values were reported. 
Clarity 
Clarity of various formulations was determined by visual 
inspection under black and white background and it was 
graded as follows: turbid +; clear ++; very clear (glassy) +++. 
The results are shown in [Table 02]. 
Homogeneity: 
All developed gels were tested for homogeneity by visual 
inspection after the gels have been set in the container. They 
were tested for their appearance and presence of any 
aggregates. The results are shown in [Table 02]. 
Consistency 
The estimation of consistency of the prepared  gels  was 
done by dropping  a cone attached to a holding  rod from a 
fixed distance of 10cm in other way that it should fall down 
on the centre of the glass cup was filled with the gel. The 
penetration by the cone was accurately measured from the 
surface of the gel to the tip of the cone inside of the gel. The 
distance traveled by cone in the period was noted down 
after 10sec. The results are shown in [Table02] 
Spreadability: 
It was determined by wooden block and glass slide 
apparatus. For the determination of Spreadability, excess of 
sample was applied in between two glass slides and then 
was compressed to uniform thickness. The weight (50gm) 
was added to pan. The time required to separate the two 
slides i.e., the time in which upper glass slide moves over the 
lower plates was taken as a measure of Spreadability(S). 
It is calculated by using the formula: S = M .L / T 
Where M = wt. tied to upper slide L = length of glass slides 
T = time taken to separate the slides The results are shown 
in [Table 02]. 
Extrudability 
Extrudability test was carried out by using Pfizer hardness 
tester. 15gm of gel was filled in collapsible aluminium tube. 
The plunger was adjusted to hold the tube properly the 
pressure of 1kg/cm2 was applied for 30 sec. The quantity of 
the gel extruded was weighed. The procedure was repeated 
at three equidistance places of the tube. The test was carried 
out in triplets.The results are shown in [Table 02]. 
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Surface pH [8] 
2.5 gm of gel was accurately weighed and dispersed in 25ml 
of distilled water. The pH of the dispersion was determined 
by using digital pH meter. The results are shown in [Table 
03]. 
Viscosity [8] 
Viscosity was determined by using Brookfield viscometer. 
Viscosity measurements were carried out at room 
temperature (25- 27°C) using a Brookfield viscometer 
(Model RVTDV II, Brookfield Engineering Laboratories, Inc, 
Stoughton, MA). The results are shown in [Table03]. 
Drug content [8] 
A specified quantity (100mg) of developed gel and marketed 
gel were taken and dissolved in 100ml of phosphate buffer 
of pH 6.8. The volumetric flask containing gel solution was 
shaken for the period 2hr on mechanical shaker in order to 
get absolute solubility of drug. This solution was filtered and 
estimated spectrophotometrically at 294.0nm using 
phosphate buffer (pH 6.8) as blank. The results are shown in 
[Table03]. 
Drug content was measured at 294nm against their blank. 
The results are shown in [Fig. 07-10]. 
Drug release kinetic studies 
Various models were tested for explaining the kinetics of 
drug release. To analyze the mechanism of the drug release 
rate kinetics of the dosage form, the obtained data was fitted 
into zero-order, first order, Higuchi and Korsmeyer Pappas 
release model, to study the drug release from the dosage 
form. The results are shown in [Table04]. 
Zero order release rate kinetics:- 
To study the zero-order release kinetics the release rate data 
are fitted to the following equation. 
                              F=K0t 
Where ‘F’ is the drug release, ‘K’ is the release rate constant 
and ‘t’ is the release time. The plot of % drug release versus 
time is linear. 
First-order release rate kinetics:- 
The release rate data are fitted to the following equation. 
Log (100-F) = kt 
A plot of log % drug release versus time is linear. 
Higuchi release model:- 
To study the Higuchi release kinetics, the release data were 
fitted to the following equation. 
F = kt1/2 
Where ‘k’ is the Higuchi constant. 
In Higuchi model, a plot of % drug release versus square 
root of time is linear. 
Korsmeyer-Pappas release model:- 
The release rate data were fitted to the following equation. 
Mt/Mœ = ktn  
Where, Mt/M∞ is the fraction of drug released, ‘K’ is the 
release constant, 
‘t’ is the release time’s’ is diffusion exponent. If n = 0.89, the 
release is zero order. If n = 0.45 the release is best explained 
by Fickian diffusion, and if0.45 < n < 0.89 then the release is 
through anomalous diffusion or non Fickian diffusion 
(Swellable & Cylindrical Matrix). In this model, a plot of log 
(Mt/M∞) versus log (time) is linear. 
The drug release data of optimized tablet were fitted to 
Zero-order, First-order, Higuchi and Korsmeyer- Pappas 
model to study the kinetics of drug release. 
Ex vivo permeation studies [9] Tissue Isolation 
Rats weighing 135-160 gm were used to obtain freshly 
excised full thickness skin. Animal was sacrificed by spinal 
dislocation. Hairs from abdominal regions was removed by 
means of surgical and razor taking care not to damage the 
epidermal surface, Subcutaneous fats was removed carefully 
without damaging to the skin. 
In vitro drug permeation through rat abdominal 
skin membrane 
In vitro permeation of transdermal gel was studied through 
the rat abdominal skin membrane. The skin membrane was 
mounted between the donor and receptor compartment of 
the standard Franz diffusion cell  with  a  diffusion area of2.1 
cm2 and the acceptor compartment volume of 21ml.The two 
chambers were tied with the help of springs so that the skin 
membrane did not move from its place. The phosphate 
buffer pH 6.8 in the acceptor compartment was continuously 
stirred at 600rpm using a magnetic stirrer. The entire setup 
was placed over a magnetic stirrer and the temperature was 
maintainedat37˚±0.5°Cbyplacingthediffusioncellin a water 
bath. The selected gel (F4) containing 1mg of Tacrolimus   
was   placed    into    the    donor compartment. The amount 
of drug permeated through the membrane was determined 
by removing aliquots from the receptor compartment and by 
replacing the same volume of buffer. The amount of 
Tacrolimus in the diffusion samples was estimated by the 
HPLC method the flux (J) through the membrane was 
calculated by using the equation. 
J = dQ / A dt 
Where J is flux (mg h-1cm-2); 
dQ/dt is the slope obtained from the steady-state portion of 
the curve and A is the area of diffusion (cm2) 
HPLC analysis: 
Instrument: youngling instrument Software: Autochro 
3000+ Column: C18, 5µm 
Lambda max: 294nm 
Temp: 35˚C 
Injection volume: 20µl  
Time -10min 
Mobile phase: Methanol: Phosphate buffer (4:1 ratio) 
PH: adjusted to 2 with HCl 
The results are shown in [Table 05] and [Fig 11] 
Skin Irritation Test 
The hair on the dorsal side of Wister albino rat was 
removed by clipping 1 day before the experiment. The 
rabbitsweredividedinto3groups.Group1servedas control; 
group 2 received optimized formulation; group 3 received 
0.8% v/v aqueous solution of formalin as a standard 
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irritant. Finally, the application sites were graded 
according to visual scoring scale. 
Stability studies 
The optimized formulation F4 was subjected to a stability 
testing for the period of three months as per ICH norms at a 
temperature of 25˚±2°C with relative humidity RH= 60±5% 
and 40º ± 2°C with relative humidity RH= 75±5%. The 
optimized formulation F4 was analyzed for the changes in 
appearance, pH, percentage of drug content and in-vitro 
diffusion study by procedure stated earlier. The results are 
shown in [Table 06]. 
RESULTS AND DISCUSSIONS 
The objective of the present study was to formulate 
Transdermal gels of Tacrolimus. Total twelve different 
Tacrolimus transdermal gels with different polymer ratios 
were prepared. In order to select the optimized formulation, 
various evaluation parameters were checked and subjected 
to in-vitro diffusion study and their release kinetic study 
were observed. The optimized formulation was further 
studied for ex-vivo permeation using rat abdominal skin. 
Preformulation studies Characterization of 
Tacrolimus: 
The following tests were performed according to British 
Pharmacopoeia. 
Description: A white or almost white powder Solubility: 
Methanol and Ethanol 
Melting Point: 296.149˚C 
From these tests it was confirmed that the sample complies 
with the monograph. 
Compatibility studies 
The incompatibility between the drug and excipients. The 
were studied by FTIR spectroscopy. The results indicate that 
there was no chemical incompatibility between drug and 
excipients. used in the formulation. The results are shown in 
[Fig 01-05]. 
Evaluation of Transdermal gels: Clarity: 
Carbopol 934P gels were found to be sparkling and 
transparent, HPMC K4M gels were found to be translucent. 
All gels were free from presence of particles. The results are 
shown in [Table 02]. 
Homogeneity: 
All developed gels (F1-F12) showed sgood homogeneity 
with absence of lumps. The developed preparations were 
much clear and transparent. The results are shown in 
[Table02]. 
Spreadability: 
The value of Spreadability indicates that the gel is easily 
spreadable by small amount of shear. In formulations F1 to 
F4, Spreadability of Carbopol 934P gel was in the range 
18.75- 27.39 g.cm/sec. In formulations F5 to F8, 
Spreadability of HPMCK4M gel was in the range 20.06- 24.27 
g.cm/sec. In formulations F9 to F12, Spreadability of Na CMC 
was in the range of 19.07- 24.57 g.cm/sec, indicating 
Spreadability of Carbopol 934P containing Diclofenac 
sodium gel i.e. F4 was good i.e. 27.39 g. cm/sec as compared 
to HPMC K4M gel and Na CMC gel. The results are shown in 
[Table02]. 
 
 
Extrudability: 
The extrusion of the gel from the tube is an important during 
its application and in patient acceptance. Gels with high 
consistency may not extrude from tube whereas, low viscous 
gels may flow quickly, and hence suitable consistency is 
required in order to extrude the gel from the tube. 
Extrudability of Carbopol 934P gel i.e. F4 formulation was 
found to be Excellent when compared to other formulations. 
The results are shown below in [Table02]. 
Surface pH: 
The pH value of all developed formulations of Carbopol gels 
(F1-F4) were in the range of 5.71- 6.27, HPMC gels (F5-F8) 
were in the range of 6.45- 6.82 and Na CMC gels (F9-F12) 
were in the range of 5.65- 6.91 which is well within the 
limits of skin pH i.e. 5.6-7.5. Hence, it was concluded that all 
the formulations could not produce any local irritation to the 
skin. The results are shown in [Table03]. 
Viscosity Measurement: 
The Viscosity of the formulations i.e. F1-F4 containing drug 
and Carbopol 934P were in the range of 1, 92,000-3,10,000 
cps, whereas the formulations i.e. F5-F8 containing drug and 
HPMC K4M were in the range of 1,36,000 – 1,47,000 cps, 
whereas formulations i.e. F9- F12 containing drug and 
Sodium CMC were in the range of 1,52,000- 1,80,000 cps. 
From the results it was found that the formulation  F1  
showed maximum viscosity i.e. 3,20,000 cps and formulation 
F8 showed minimum viscosity i.e. 1,36,000cps.The results 
are shown in[Table03]. 
Drug Content: 
The percentage drug content of all prepared gel 
formulations i.e. F1 to F12 were found to be in the range of 
97.21±0.18 to 101.46±0.26%. The percentage drug content 
of formulations was found to be within the I.P limits. Hence 
methods adopted for gels formulations were found suitable. 
The results are shown in [Table 03]. 
In-vitro drug diffusion studies: 
In-vitro drug release study of different gel formulations i.e. 
F1 to F12 were carried out through dialysis sac (cellophane 
membrane) and are plotted. The percentage drug release for 
the formulations containing drug and Carbopol 934P i.e. F1 
to F4 were found to be in the range of 82.88% to 98.68% in 6 
hours. Among these formulations, formulation F4 containing 
drug and Carbopol 934P in the ratio1:2 showed high 
percentage of drug release i.e. 98.68%in 6 hours. The results 
indicate that increase in the concentration of Carbopol 934p, 
increases the drug release. 
The percentage drug release for the formulations containing 
drug and HPMC K4M i.e. F5-F8 were in the range of 79.59 – 
87.72% in 6 hours. Among these, formulation F8 containing 
drug and HPMCK4M in the ratio 1:4 showed highest 
percentage of drug release i.e. 87.72% in 6 hours. From the 
above it was observed that increase in the concentration of 
HPMC K4M, increases the drug release. The percentage drug 
release for the formulations containing drug and Na CMC i.e. 
F9-F12 were found to be in the range of 83.77 – 90.38% in 6 
hours. Among these, the formulation F10 containing drug 
and Na- CMC in the ratio 1:1.5 showed highest percentage 
drug release of drug release i.e. 90.38% in 6 hours. From the 
above it was observed that increase in the concentration of 
Na CMC increases the drug release. The comparison of in-
vitro drug release studies were conducted for the 
formulations F4, F8 and F10. The results are shown in [Fig 
07-10]. 
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From the above result it is observed that the formulation F4 
containing drug and Carbopol 934P in the ratio 1:2 showed 
highest percentage drug release i.e. 98.68% in 6 hours. 
Drug release kinetics: 
In-vitro drug release data of F1 to F12 were fitted to zero 
order, first order, and Higuchi and Korsmeyer-Pappas 
equations to ascertain the pattern of drug release. The 
results are shown in [Table 04]. In-vitro drug release data 
for all the formulations F1 to F12 were subjected to release 
kinetic study according to Zero order, First order, Higuchi 
and Korsemeyer-Peppas equation to ascertain the 
mechanism of drug release. Among the zero-order and first-
order, the R2 values were found to be higher in zero-order. 
So, all the formulations followed zero-order kinetics. But in 
case of mechanism of drug release, between Higuchi and 
Korsemeyer-Peppas equation, the R2 value were found to be 
higher in Korsemeyer-Peppas equation and release 
exponent “n” value less than 1 i.e. (n > 0.5). This indicates 
that all the formulations followed non- Fickian diffusion. 
Hence it was concluded that all the formulations followed 
zero-order drug release with non-Fickian diffusion. 
Ex-vivo permeation studies: 
It was concluded that the formulation F4 containing drug, 
Carbopol 934P in the ratio 1:2, showed good Spreadability, 
Extrudability and in-vitro drug release. On the basis of above 
results formulation F4 was studied for ex-vivo permeation 
using rat abdominal skin. The optimized formulation was 
analyzed by HPLC method at 285nm for 6hrs release 
through rat abdominal skin. The flux was calculated. 
The results of drug permeation from optimized formulation 
through the rat abdominal skin revealed that Tacrolimus 
was released from the optimized formulation and permeate 
through the rat abdominal membrane and could possibly 
permeate through the human abdominal membrane. The 
drug permeation from F4 was slow and steady and 0.89gm 
of Tacrolimus could permeate through the skin membrane 
with a flux of 0.071 gm hr-1 cm-2. The results are shown in 
[Table 05]. 
Skin irritation test: 
Based on in-vitro diffusion study formulation F4 containing 
drug and Carbopol 934P in the ratio 1:2 was optimized. 
Further, Skin irritation test was performed with optimized 
formulation F4 in white rabbits divided in 3 groups. It was 
found that the gel F4 causes no irritation or Erythema. 
Stability Studies: 
Accelerated stability studies was conducted in best 
formulation F4, according to ICH guidelines i.e. 
25˚±2˚C/60±5%RH for first 30 days and 40˚±2˚C/75±5%RH 
up to 90 days. The results indicate that there was no so 
much change in appearance, pH, drug content and in-vitro 
drug release studies. The results are shown in [Table 06].
 
Table 1: Formula for the preparation of Tacrolimus Transdermal gels using Carbopol 934P, HPMCK4M and Sodium 
CMC. 
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 
Tacrolimus (gm) 1 1 1 1 1 1 1 1 1 1 1 1 
Carbopol 934P (gm) 0.5 1 1.5 2 - - - - - - - - 
HPMC K4M (gm) - - - - 2.5 3 3.5 4 - - - - 
Sodium CMC - - - - - - - - 1 1.5 2 2.5 
Triethanolamine (ml) 0.4 0.6 0.8 1.0 - - - - - - - - 
Alcohol (ml) 20 20 20 20 - - - - - - - -- 
Propylene glycol (ml) 10 10 10 10 30 30 30 30 30 30 30 30 
PEG 400 (ml) - - - - 7 7 7 7 7 7 7 7 
Distilled water (ml) Q.S Q.S Q.S Q.S Q.S Q.S Q.S Q.S Q.S Q.S Q.S Q.S 
 
 
Figure 1& 2: transmission electron microscopy (TEM) images of the prepared Tacrolimusgel 
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Table 2: Clarity, Homogeneity, Spreadability, Extrudability Parameters 
Formulation Code Clarity Homogeneity Spreadability Extrudability 
F1 + Satisfactory 18.75 + 
F2 ++ Good 19.85 ++ 
F3 ++ Good 22.55 ++ 
F4 +++ Excellent 27.39 +++ 
F5 ++ Good 20.06 + 
F6 ++ Good 21.08 ++ 
F7 ++ Good 23.54 ++ 
F8 ++ Good 24.27 + + 
F9 ++ Good 19.07 ++ 
F10 +++ Excellent 21.81 +++ 
F11 ++ Good 24.57 ++ 
F12 ++ Good 23.25 ++ 
 
Table 3: pH, Viscosity and Drug Content (%) 
Formulation code pH Viscosity (cps) Drug Content (%) 
F1 5.71±0.05 3,20,000 98.53±0.21 
F2 5.79±0.15 1,92,000 97.21±0.18 
F3 6.12±0.02 2,40,000 98.92±0.27 
F4 6.27±0.03 3,10,000 101.3±0.22 
F5 6.64±0.02 1,44,000 101.46±0.26 
F6 6.45±0.07 1,47,000 98.92±0.25 
F7 6.82±0.05 1,38,000 98.82±0.31 
F8 6.60±0.04 1,36,000 99.95±0.18 
F9 6.91±0.02 1,52,000 97.94±0.33 
F10 6.73±0.09 1,60,000 98.08±0.40 
F11 5.98±0.12 1,70,000 97.24±0.38 
F12 5.65±0.14 1,80,000 99.13±0.19 
 
Table 4: Drug release kinetics of all the formulations (F1 - F12) 
Formulation code Zero order First order Korsmeyer-Pappas Higuchi 
R2 R2 R2 N R2 
F1 0.989 0.899 0.996 0.783 0.955 
F2 0.990 0.871 0.997 0.780 0.955 
F3 0.989 0.870 0.990 0.7765 0.951 
F4 0.990 0.932 0.997 0.784 0.953 
F5 0.990 0.922 0.993 0.788 0.951 
F6 0.990 0.908 0.995 0.789 0.952 
F7 0.984 0.969 0.944 0.784 0.927 
F8 0.987 0.963 0.972 0.809 0.939 
F9 0.989 0.927 0.983 0.787 0.942 
F10 0.982 0.977 0.980 0.774 0.952 
F11 0.987 0.967 0.972 0.789 0.940 
F12 0.985 0.970 0.960 0.793 0.936 
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Table 5: Ex-vivo drug permeation of optimized Formulation F4 
Time (h) Cumulative drug permeated (gm) 
0 0 
1 0.17 
2 0.31 
3 0.49 
4 0.62 
5 0.77 
6 0.89 
 
Table 6: Stability studies of formulation F4 
Formulation Days Temperature and   
Relative Humidity 
Appearance pH Drug 
content 
In-vitro drug 
release 
F4 0 25˚±2˚C/60±5% RH Clear 6.27 101.3 98.68 
F4 15 25˚±2˚C/60±5% RH Clear 6.25 101.1 98.60 
F4 30 25˚±2˚C/60±5% RH Clear 6.20 99.8 98.50 
F4 60 40˚±2˚C/75±5% RH Clear 6.18 99.5 98.35 
F4 90 40˚±2˚C/75±5% RH Clear 6.15 99.2 98.20 
 
 
 
 
Figure 3&4: FTIR Spectra 
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Figure 5 to 8 : FTIR Spectra 
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Figure 9 to 13: Drug release kinetics of all the formulations (F1 - F12) 
 
CONCLUSION 
It was observed that Carbopol 934P gel containing 
Tacrolimus in 1:2 ratios (F4) produced better Spreadability 
and consistency as compared to other formulations. The 
developed F4 gel showed good homogeneity, suitable pH, no 
skin irritation and good stability. The maximum percentage 
of drug  release was found to be 98.68% in 6 hours in 
formulation F4. The drug permeation from optimized 
formulation i.e. F4 was slow and steady and 0.89 gm of 
Diclofenac sodium could permeated through rat abdominal 
skin membrane with a flux 0.071 gm hr-1 cm-2 and could 
possibly permeate through human abdominal membrane. 
The Carbopol 934P forms water washable gel because of its 
water solubility and has wider prospects to be used as a 
topical drug delivery system. 
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